DOI:
10.1055/s-00049561
South Asian Journal of Cancer
LinksClose Window
References
Sonneveld P, van der Holt B, Segeren CM. et al; Dutch-Belgian Hemato-Oncology Cooperative Group (HOVON).
Intermediate-dose melphalan compared with myeloablative treatment in multiple myeloma: long-term follow-up of the Dutch Cooperative Group HOVON 24 trial.
Haematologica 2007;
92 (07) 928-935
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.